PRESIDENT ENDOCRINE TECHNOLOGY, LLC NY, New York, United States
Abstract Text: Problem: Diabetes and its treatment is complex, Extremely costly and outcome is heterogenous. There are many unanswered questions in the treatment and its cure potential. Unanswered questions are how to protect Beta cells?, prevent and treat target organ damage? at cellular/sub cellular levels that are beyond evidenced based medicine and how to optimize drug therapy?, clinical responses and preventive therapies.? Potential Solutions: During recent GTC meeting in 2024 NVIDIA announces new robotics products that are not only automated but can be trained with artificial intelligence. Humanoid Robot --GR00T stands for “Generalist Robot 00 Technology,” and with the race for humanoid robotics heating up, this new technology is intended to help accelerate development. GR00T is a large multimodal model (LMM) providing robotics developers with a generative AI platform to begin the implementation of large language models (LLMs). training with vast amount of data input/(https://www.therobotreport.com/nvidia-announces-new-robotics-products-at-gtc-2024/) Solution: Based on our patented technology for the cure of Type 1 and Type 2 diabetes - we plan to develop Super consultancy model for diabetes treatment and its cure. The target group are various end group users such as hospitals, physicians, endocrinologists, researchers and biotechnology companies. It is expected when successfully developed --it will reduce cost and allow rapid improvement in the diabetes and its complications.
